Literature DB >> 28110088

Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder.

Patrick D Worhunsky1, David Matuskey2, Jean-Dominique Gallezot3, Edward C Gaiser2, Nabeel Nabulsi3, Gustavo A Angarita4, Vince D Calhoun5, Robert T Malison4, Marc N Potenza6, Richard E Carson3.   

Abstract

Dopamine type 2 and type 3 receptors (D2R/D3R) appear critical to addictive disorders. Cocaine-use disorder (CUD) is associated with lower D2R availability and greater D3R availability in regions primarily expressing D2R or D3R concentrations, respectively. However, these CUD-related alterations in D2R and D3R have not been concurrently detected using available dopaminergic radioligands. Furthermore, receptor availability in regions of mixed D2R/D3R concentration in CUD remains unclear. The current study aimed to extend investigations of CUD-related alterations in D2R and D3R availability using regional and source-based analyses of [11C]-(+)-PHNO positron emission tomography (PET) of 26 individuals with CUD and 26 matched healthy comparison (HC) participants. Regional analysis detected greater binding potential (BPND) in CUD in the midbrain, consistent with prior [11C]-(+)-PHNO research, and lower BPND in CUD in the dorsal striatum, consistent with research using non-selective D2R/D3R radiotracers. Exploratory independent component analysis (ICA) identified three sources of BPND (striatopallidal, pallidonigral, and mesoaccumbens sources) that represent systems of brain regions displaying coherent variation in receptor availability. The striatopallidal source was associated with estimates of regional D2R-related proportions of BPND (calculated using independent reports of [11C]-(+)-PHNO receptor binding fractions), was lower in intensity in CUD and negatively associated with years of cocaine use. By comparison, the pallidonigral source was associated with estimates of regional D3R distribution, was greater in intensity in CUD and positively associated with years of cocaine use. The current study extends previous D2R/D3R research in CUD, demonstrating both lower BPND in the D2R-rich dorsal striatum and greater BPND in the D3R-rich midbrain using a single radiotracer. In addition, exploratory ICA identified sources of [11C]-(+)-PHNO BPND that were correlated with regional estimates of D2R-related and D3R-related proportions of BPND, were consistent with regional differences in CUD, and suggest receptor alterations in CUD may also be present in regions of mixed D2R/D3R concentration.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Cocaine use disorder; Dopamine; Independent component analysis; Striatum; [(11)C]-(+)-PHNO

Mesh:

Substances:

Year:  2017        PMID: 28110088      PMCID: PMC5344702          DOI: 10.1016/j.neuroimage.2017.01.045

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  67 in total

1.  Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior.

Authors:  Janet L Neisewander; Rita A Fuchs; Ly T L Tran-Nguyen; Suzanne M Weber; Greg P Coffey; Jeffrey N Joyce
Journal:  Neuropsychopharmacology       Date:  2004-08       Impact factor: 7.853

2.  Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55.

Authors:  Timothy H C Cheung; Amy L Loriaux; Suzanne M Weber; Kayla N Chandler; Jeffrey D Lenz; Romina F Schaan; Robert H Mach; Robert R Luedtke; Janet L Neisewander
Journal:  J Pharmacol Exp Ther       Date:  2013-09-09       Impact factor: 4.030

3.  Effects of chronic cocaine abuse on postsynaptic dopamine receptors.

Authors:  N D Volkow; J S Fowler; A P Wolf; D Schlyer; C Y Shiue; R Alpert; S L Dewey; J Logan; B Bendriem; D Christman
Journal:  Am J Psychiatry       Date:  1990-06       Impact factor: 18.112

4.  An information-maximization approach to blind separation and blind deconvolution.

Authors:  A J Bell; T J Sejnowski
Journal:  Neural Comput       Date:  1995-11       Impact factor: 2.026

5.  Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO.

Authors:  David Matuskey; Jean-Dominique Gallezot; Brian Pittman; Wendol Williams; Jane Wanyiri; Edward Gaiser; Dianne E Lee; Jonas Hannestad; Keunpoong Lim; Minq-Qiang Zheng; Shu-fei Lin; David Labaree; Marc N Potenza; Richard E Carson; Robert T Malison; Yu-Shin Ding
Journal:  Drug Alcohol Depend       Date:  2014-03-20       Impact factor: 4.492

6.  Cocaine uptake is decreased in the brain of detoxified cocaine abusers.

Authors:  N D Volkow; G J Wang; J S Fowler; J Logan; R Hitzemannn; S J Gatley; R R MacGregor; A P Wolf
Journal:  Neuropsychopharmacology       Date:  1996-03       Impact factor: 7.853

7.  Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy.

Authors:  Andri C Tziortzi; Graham E Searle; Sofia Tzimopoulou; Cristian Salinas; John D Beaver; Mark Jenkinson; Marc Laruelle; Eugenii A Rabiner; Roger N Gunn
Journal:  Neuroimage       Date:  2010-06-30       Impact factor: 6.556

Review 8.  Dopamine agonists for the treatment of cocaine dependence.

Authors:  Silvia Minozzi; Laura Amato; Pier Paolo Pani; Renata Solimini; Simona Vecchi; Franco De Crescenzo; Piergiorgio Zuccaro; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2015-05-27

9.  Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.

Authors:  Buyean Lee; Edythe D London; Russell A Poldrack; Judah Farahi; Angelo Nacca; John R Monterosso; Jeanette A Mumford; Andrew V Bokarius; Magnus Dahlbom; Jogeshwar Mukherjee; Robert M Bilder; Arthur L Brody; Mark A Mandelkern
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

10.  In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.

Authors:  Eugenii A Rabiner; Mark Slifstein; Jose Nobrega; Christophe Plisson; Mickael Huiban; Roger Raymond; Mustansir Diwan; Alan A Wilson; Patrick McCormick; Gabriella Gentile; Roger N Gunn; Marc A Laruelle
Journal:  Synapse       Date:  2009-09       Impact factor: 2.562

View more
  20 in total

Review 1.  Selectivity of probes for PET imaging of dopamine D3 receptors.

Authors:  Robert K Doot; Jacob G Dubroff; Kyle J Labban; Robert H Mach
Journal:  Neurosci Lett       Date:  2018-03-05       Impact factor: 3.046

Review 2.  CNS metabolism in high-risk drug abuse : Insights gained from 1H-, 31P-MRS and PET.

Authors:  S Bodea
Journal:  Radiologe       Date:  2018-11       Impact factor: 0.635

3.  Longitudinal changes in network engagement during cognitive control in cocaine use disorder.

Authors:  Kristen P Morie; Elise E DeVito; Marc N Potenza; Patrick D Worhunsky
Journal:  Drug Alcohol Depend       Date:  2021-10-30       Impact factor: 4.492

Review 4.  [CNS metabolism in high-risk drug abuse, German version : Insights gained from 1H- and 31P MRS and PET].

Authors:  S V Bodea
Journal:  Radiologe       Date:  2017-06       Impact factor: 0.635

5.  Separating dopamine D2 and D3 receptor sources of [11C]-(+)-PHNO binding potential: Independent component analysis of competitive binding.

Authors:  Kelly Smart; Jean-Dominique Gallezot; Nabeel Nabulsi; David Labaree; Ming-Qiang Zheng; Yiyun Huang; Richard E Carson; Ansel T Hillmer; Patrick D Worhunsky
Journal:  Neuroimage       Date:  2020-03-19       Impact factor: 6.556

6.  Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.

Authors:  Yasmin Zakiniaeiz; Ansel T Hillmer; David Matuskey; Nabeel Nabulsi; Jim Ropchan; Carolyn M Mazure; Marina R Picciotto; Yiyun Huang; Sherry A McKee; Evan D Morris; Kelly P Cosgrove
Journal:  Neuropsychopharmacology       Date:  2019-07-03       Impact factor: 7.853

7.  Dysregulation of Decision Making Related to Metabotropic Glutamate 5, but Not Midbrain D3, Receptor Availability Following Cocaine Self-administration in Rats.

Authors:  Stephanie M Groman; Ansel T Hillmer; Heather Liu; Krista Fowles; Daniel Holden; Evan D Morris; Daeyeol Lee; Jane R Taylor
Journal:  Biol Psychiatry       Date:  2020-06-29       Impact factor: 13.382

8.  Dopamine D2/3 receptor availability in cocaine use disorder individuals with obesity as measured by [11C]PHNO PET.

Authors:  David Matuskey; Gustavo A Angarita; Patrick Worhunsky; Sheida Koohsari; Paul Gravel; Brian Pittman; Edward C Gaiser; Jean-Dominque Gallezot; Nabeel Nabulsi; Yiyun Huang; Richard E Carson; Marc N Potenza; Robert T Malison
Journal:  Drug Alcohol Depend       Date:  2021-01-08       Impact factor: 4.492

9.  Relationships between dopamine D2/3 receptor availability and social-environmental factors in humans.

Authors:  Katina C Calakos; Aleksandra Rusowicz; Brian Pittman; Jean-Dominique Gallezot; Marc N Potenza; Kelly P Cosgrove; David Matuskey
Journal:  Neurosci Lett       Date:  2022-01-17       Impact factor: 3.046

10.  Multimodal investigation of dopamine D2/D3 receptors, default mode network suppression, and cognitive control in cocaine-use disorder.

Authors:  Patrick D Worhunsky; Gustavo A Angarita; Zu Wei Zhai; David Matuskey; Jean-Dominique Gallezot; Robert T Malison; Richard E Carson; Marc N Potenza
Journal:  Neuropsychopharmacology       Date:  2020-10-02       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.